Researchers are excited about the medication , a groundbreaking dual agonist showing remarkable data in initial trials for body loss . It acts by impacting both hormones : GLP-1 and GIP, which , when https://qasiminny494396.blogginaway.com/41522322/the-new-hope-for-size-management